Award details

Rational Engineering of Advanced Clostridia for Transformational Improvements in Fermentation (REACTIF)

Reference	BB/L000105/1
Principal Investigator / Supervisor	Professor Nigel Minton
Co-Investigators / Co-Supervisors	Dr Klaus Winzer, Dr Ying Zhang
Institution	University of Nottingham
Department	Sch of Molecular Medical Sciences
Funding type	Research
Value (£)	368,068
Status	Completed
Type	Research Grant
Start date	01/04/2013
End date	31/10/2016
Duration	43 months

Abstract

The clostridial-based butanol fermentation is an old industrial process, developed in 1912. The process became uneconomic in the mid 1950's when it could no longer compete with the petrochemical industry. Although recently revived in China, many of the plants are struggling because the technology is not sufficiently advanced and is reliant on expensive and non-sustainable starchy feedstocks. This project seeks to rectify this deficiency through the development of improved commercial strains able to achieve high butanol productivity and capable of fermenting non-food, cellulosic feedstocks. Strains will exhibit greater tolerance to commercial process conditions, feedstock inhibitors and butanol end titres and offer a transformational change to fermentation performance and process economics. Results will include:- - Reproducible feedstock & defined process conditions - Advanced methods for strain selection (transposon mediated and continuous culture) - The identification and characterisation of beneficial tolerance traits - Advanced GBL production strains proven at pilot scale (and ready to commercialize) - Novel integrated process design for hydrolysis/fermentation - Cost models (and cost savings) & calculations for energy & GHG emissions The Consortium has an excellent balance between industry and academia that fills the entire supply chain (from feedstock to product). Three world class academic groups (University of Nottingham, Ulm & Gottingen) are complemented and supported by two industrial partners (Weyland & Green Biologics) who will provide significant technical input, financial support, commercial steerage and market opportunities. GBL is a world leader in commercialization activities for biobutanol fermentation and Weyland is a world leading developer of sugars from cellulosic feedstocks. Together the industrial partners will deliver an integrated process solution for producing butanol from a cellulosic feedstock and demonstrate at pilot-scale.

Summary

CONTEXT n-Butanol is a valuable platform chemical with a large market (>3 M tonne/yr). It is used as a chemical precursor for a variety of polymers, plastics and solvents with a global market worth ~$8 billion). Average growth is about 3.2% with demand concentrated in N. America (28%), Western Europe (23%) and North East Asia (35%). Virtually all n-butanol today is synthetic and produced from propylene (derived from oil). The fermentation route to butanol is an old industrial process that was developed in the UK in 1912 and spread quickly to the N. America, S.Africa, Japan and Russia. It is reliant on a bacteria called Clostridia, which ferments sugar-rich liquors and converting them to butanol, in a similar way to which yeasts is employed in brewing to make ethanol. The commercial butanol fermentation process became uneconomic in the mid 1950's when it could no longer compete with petro-derived equivalents from low cost oil and gradually disappeared. More recently, the fermentation has been re-commercialized in China with at least 6 new plants and capacity for >300,000 T solvent/yr. However, these plants are struggling because the technology is not sufficiently advanced, the bacterial strains produce low amounts of butanol (due to butanol toxicity) and they rely on expensive starch-rich plant material as the source of sugar for the fermentation. Aside from the prohibitive cost of such feedstocks, their use for this purpose conflicts with a possible use as a food for human consumption. There is, therefore, a need to derive the sugar used from non-food plant derived material, the so-called lignocellulose component. Lignocellulose is the most abundant source of carbon on the plant. However, it is particularly recalcitrant to breakdown, and the treatments required (acid, alkali or steam explosion) to its conversion into sugar frequently leads to the formation of by-products that inhibit bacterial growth, so-called 'inhibitors'. AIMS & OBJECTIVES Today, advances in fermentation technology and the utilization of cheaper feedstocks, together with novel gene-based methods for strain improvement have the potential to transform fermentation process economics. We have assembled an exceptional group of academic and industrial partners, with specific expertise in the Clostridia fermentation. The industrial partners bridge the commercial supply chain (from feedstock to butanol production) whilst the academic groups focus on delivery of advanced microbes and superior fermentation performance using an array of advanced molecular biology techniques. Our objectives are to:- 1. identify and characterise tolerance traits (to high butanol titres and lignocellulose-derived inhibitors), both in historical strains that were used commercially over four decades and in current production strains following the implementation of novel directed evolution strategies; 2. transfer the identified alleles into current, robust production strains, together with rationale metabolic engineering to improve product titres, and; 3. assessment of strain(s) performance on cellulosic feedstocks at lab and pilot scale APPLICATIONS AND BENEFITS The project will deliver advanced Clostridia strains that offer a transformational change to fermentation performance and process economics of butanol production. Advanced strains not only improve fermentation performance but they will enable plant owners to switch to lower cost and more environmentally friendly cellulosic feedstocks. The production of butanol from renewable plant biomass as opposed to fossil fuels will provide a net reduction in greenhouse gas emission, contributing to a reduction in global warming and reducing the effects of environmental pollution on human health. Biobutanol has the potential to directly replace all synthetic butanol addressing a specific market need in the chemical industry for cost efficient renewable chemical replacements, particularly in Europe & N. America

Impact Summary

WHO WILL BENEFIT? The overall aim of this project is to enhance and extend the capabilities of solventogenic bacteria in terms of fuel and chemical production from renewable and sustainable resources. As this is an Industrial Partnership, the primary beneficies other than the Academic groups involved (University of Nottingham, Ulm and Goettingen) is GBL and Weyland. They will directly commercialise all useful strains that emerge from the project and will have first refusal on any foreground intellectual property that arises. All parties have extensive global networks of existing commercial contacts and strategic partners. For example, GBL have partnerships with Guangxi Jinyuan Biochemical and Lianyungang Union of Chemicals in China. Nottingham have partnerships/ collaborations with EBI, Qteros, Lanxess and Genencor (N America), Evonik, Universities of Munich, Ulm and Berlin (Germany), TMO Renewables Ltd, Invista and Unilever (UK), Metabolic Explorer Ltd, INRA and CNRS (France), Chinese Academy of Sciences (Shanghai and Tsinghau, China), the Mumbai Institute of Chemical Technology (India) and LanzaTech (New Zealand). Working together, the consortium will seek to maximise these links for the benefit of all partner organisations involved. The successful commercialization of anticipated outputs will have a rapid and global impact for both humanity and the environment. It will reduce greenhouse gas emissions and environmental pollution, provide an alternative to the use of food or farm resources for the production of low cost low carbon fuels and chemicals. It is therefore of benefit to society, ultimately impacting on health and well-being. HOW WILL THEY BENEFIT? Project outcomes will and allow improved fermentation process economics and product diversity, thus encouraging more rapid and wide spread adoption of clostridia-based butanol fermentation as a process to produce high volumes of low cost butanol as a chemical commodity and potentially as a biofuel. The partnership are anticipated to directly benefit from the outputs of the project through their commercial adoption via the pipeline and partnerships established by GBL and Weyland to both scale-up and commercially produce fuel and chemical products by clostridia fermentation. Additionally the partnership intends to explore strategic licensing deals with third party organisations. These will take the form of up front and milestone payments as well as ongoing royalty streams. The successful scale-up and commercialization of processes will assist the UK and Europe in meeting challenging 'greenhouse' gas reduction targets, and contribute to indirectly to food security. The generation of butanol from cellulosic feedstocks will additionally impact on reducing reliance on fossil reserves, and therefore increase national fuel security.

Committee	Research Committee D (Molecules, cells and industrial biotechnology)
Research Topics	Bioenergy, Industrial Biotechnology, Microbiology
Research Priority	X – Research Priority information not available
Research Initiative	ERA-NET Industrial Biotechnology (ERANETIB) [2012-2014]
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search